Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Sep 1;1866(9):165559.
doi: 10.1016/j.bbadis.2019.165559. Epub 2019 Oct 23.

Cellular models of Batten disease

Affiliations
Review

Cellular models of Batten disease

Christopher J Minnis et al. Biochim Biophys Acta Mol Basis Dis. .

Abstract

The Neuronal Ceroid Lipofuscinoses (NCL), otherwise known as Batten disease, are a group of neurodegenerative diseases caused by mutations in 13 known genes. All except one NCL is autosomal recessive in inheritance, with similar aetiology and characterised by the accumulation of autofluorescent storage material in the lysosomes of cells. Age of onset and the rate of progression vary between the NCLs. They are collectively one of the most common lysosomal storage diseases, but the enigma remains of how genetically distinct diseases result in such remarkably similar pathogenesis. Much has been learnt from cellular studies about the function of the proteins encoded by the affected genes. Such research has utilised primitive unicellular models such as yeast and amoeba containing gene orthologues, cells derived from naturally occurring (sheep) and genetically engineered (mouse) animal models or patient-derived cells. Most recently, patient-derived induced pluripotent stem cell (iPSC) lines have been differentiated into neural cell-types to study molecular pathogenesis in the cells most profoundly affected by disease. Here, we review how cell models have informed much of the biochemical understanding of the NCLs and how more complex models are being used to further this understanding and potentially act as platforms for therapeutic efficacy studies in the future.

Keywords: Batten disease; Cellular models; Ceroid; NCL; Neurodegeneration; Yeast.

PubMed Disclaimer

References

    1. Botstein, D. & Fink, G. R. Yeast - an experimental organism for modern biology. Science 240, 1439–1443, doi:DOI 10.1126/science.3287619 (1988). - DOI - PubMed
    1. Botstein D., Fink G.R. Yeast: an experimental organism for 21st century biology. Genetics. 2011;189:695–704. doi: 10.1534/genetics.111.130765. - DOI - PMC - PubMed
    1. Goffeau A. Four years of post-genomic life with 6,000 yeast genes. FEBS Lett. 2000;480:37–41. - PubMed
    1. Goffeau, A. et al. Life with 6000 genes. Science 274, 546-&, doi:DOI 10.1126/science.274.5287.546 (1996). - DOI - PubMed
    1. Wood, V. et al. The genome sequence of Schizosaccharomyces pombe. Nature 415, 871–880, doi:DOI 10.1038/nature724 (2002). - DOI - PubMed

Publication types

LinkOut - more resources